| Type: | combo |
| Component1: | DTaP vaccine |
| Class1: | Vaccine |
| Component2: | Inactivated poliovirus vaccine |
| Class2: | Vaccine |
| Tradename: | Kinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others |
| Pregnancy Au: | A |
| Legal Status: | Rx-only |
| Routes Of Administration: | Intramuscular injection |
| Cas Number: | 1688606-07-6 |
| Atc Prefix: | J07 |
| Atc Suffix: | CA02 |
| Synonyms: | diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) |
DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).[1] [2]
It is also known as DTaP/IPV, dTaP/IPV, DTPa-IPV, or DPT-IPV.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.[1]
Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[3] and Quadracel from Sanofi Pasteur.[4]
Repevax is available in the UK.[5] [6]
Within Japan, the formulation is called 四種混合(shishukongou - "mixture of 4").Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic').[7] [8] A previous product by Takeda Pharmaceutical Company has been withdrawn by the company.[9]